Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2025-12-25 @ 4:01 PM
NCT ID: NCT02203357
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT02203357
Study Brief: A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
20μg, 0-1-6 117 young adults were administered with 20μg of hepatitis B vaccine according to the 0-1-6 mon schedule. None None 0 117 2 117 View
60μg, 0-1 111 young adults were administered with 60μg of hepatitis B vaccine according to the 0-1 mon schedule. None None 0 111 2 111 View
60μg, 0-2 125 young adults were administered with 60μg of hepatitis B vaccine according to the 0-2 mon schedule. None None 0 125 5 125 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
injection site pain SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View